Live Breaking News & Updates on Mike Mcelhaugh

Stay updated with breaking news from Mike mcelhaugh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Arbutus Third Quarter Corporate and Financial Update Conference Call. ....

City Of , United Kingdom , David Hastings , Dave Hastings , Mike Mcelhaugh , Bristol Myers Squibb , Michaelj Mcelhaugh , Roy Buchanan , Karen Sims , Lisa Caperelli , Arbutus Biopharma Corp , Arbutus Biopharma Corporation , Call Transcript November , Biopharma Corporation , Arbutus Third Quarter Corporate , Financial Update Conference , Bill Collier , Chief Executive Officer , Chief Financial Officer , Chief Operating Officer , Mike Sofia , Chief Scientific Officer , Chief Medical , Liver Meeting , Barinthus Bio Therapeutics , Chief Operating ,

Arbutus Biopharma (ABUS) Announces CEO, William Collier, to Retire December 31

Arbutus Biopharma (ABUS) Announces CEO, William Collier, to Retire December 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Frank Torti , Mike Mcelhaugh , Michaelj Mcelhaugh , William Collier , Arbutus Biopharma Corporation Nasdaq , Arbutus Biopharma Corporation , Chief Executive Officer , Chief Operating Officer , Interim President ,

Arbutus Announces CEO, William Collier, to Retire December 31, 2023

Arbutus Announces CEO, William Collier, to Retire December 31, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lisam Caperelli , Mike Mcelhaugh , Oncore Biopharma , William Collier , Michaelj Mcelhaugh , Bristol Myers Squibb , Frank Torti , Viropharma Inc , Business Development , Co Inc , Gilead Sciences Inc , Market Analytics At Pharmasset Inc , Arbutus Biopharma Corporation Nasdaq , Securities Exchange , Joseph University , Thomas Jefferson University , Arbutus Co Founder , Biopharma Corporation , Chief Executive Officer , Chief Operating Officer , Interim President , Chief Business Officer , Senior Vice President , Commercial Strategy , Chief Operating , Hepatitisc Worldwide Commercialization ,

Arbutus Announces CEO, William Collier, to Retire December 31, 2023 - Arbutus Biopharma (NASDAQ:ABUS)

Michael J. McElhaugh, Arbutus Co-founder and COO, to Serve as Interim CEO WARMINSTER, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical-stage ....

William Collier , Frank Torti , Michaelj Mcelhaugh , Lisam Caperelli , Oncore Biopharma , Mike Mcelhaugh , Bristol Myers Squibb , Securities Exchange , Business Development , Market Analytics At Pharmasset Inc , Gilead Sciences Inc , Thomas Jefferson University , Arbutus Biopharma Corporation , Joseph University , Viropharma Inc , Co Inc , Arbutus Co Founder , Chief Executive Officer , Chief Operating Officer , Interim President , Chief Business Officer , Senior Vice President , Commercial Strategy , Chief Operating , Hepatitisc Worldwide Commercialization , Market Analytics ,